Diabetic injection pens are the special insulin injectable pens used by the patients suffering from diabetes. These pens are with precision designed for the patients to avoid the regular or periodic visits to the diabetic doctor and also get free of the hesitation of the needles used by doctors for injection of the insulin. An average diabetic pen contains a dial that measures the dosage, a cartridge, and a disposable needle. The insulin pens of the diabetic pens are gaining popularity speedily in the modern work especially due to the rising prevalence of the diabetic patients, the improvements in the diabetic pens, making them easier to use and causing less pain, and also convenient delivery of the insulin.
Diabetic injection pens market was estimated to be over US$ 6.5 billion in 2019. It is anticipated to grow at a digit CAGR of 7.5% from 2019 to 2030.
There are several factors propelling the growth of diabetic injection pen market, some of which are increasing prevalence of diabetes, growing geriatric population with diabetes and growth in popularity of diabetic injector pens among patients. Moreover, innovative advancements such as digital insulin pens and acceptance of these pens among population are anticipated to drive the market during the forecast period. To obtain better insights regarding the market scenario prominent players are focusing on organic growth strategies such as product approval, product launches, increasing focus on R&D activities to launch innovative products in the market. For instance, scientists are advancing their research to reduce the number of insulin injections which are required to maintain glycemic control, and to prevent hypoglycemic (low blood glucose) episodes.
Major Key Players of the Diabetic Injection Pens Market are:
Novo Nordisk A/S, AstraZeneca, Eli Lilly and Company, BD, Sanofi, Owen Mumford Ltd., Shanghai Benemae Pharmaceutical Corporation, Jiangsu Delfu medical device Co.,Ltd, F. Hoffmann-La Roche Ltd & Biocon among others.
Download PDF to Know the Impact of COVID-19 on “Diabetic Injection Pens Market” at: https://www.marketindustryreports.com/pdf/246
According to The International Diabetes Federation (IDF), in 2019, approximately 463 million adults (20-79 years) were living with diabetes and by 2045 this number is anticipated to rise to 700 million. Moreover, diabetes caused around 4.2 million deaths in 2019. Thus, the rising cases of diabetes among population and the growing adoption of these insulin pens among the population are the factors anticipated to play a key role in the growth of diabetic injection pens market.
The Diabetic Injection Pens Market is segmented on the basis of Usage, Product Type, Distribution Channel and region.
Major Usage of Diabetic Injection Pens Market covered are:
- Reusable Pens
- Disposable Pens
Major Product Type of Diabetic Injection Pens Market covered are:
- Insulin Pens
- Pen Needles
Major Distribution Channel of Diabetic Injection Pens Market covered are:
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
Moreover, the technology has positively influenced the growth of diabetic injection pens such improving healthcare outcome, greater accuracy and convenience of monitoring data easily. For instance, ESYSTA system, a product manufactured by Emperra GmbH E-Health Technologies which is fully automated, transmits data from the blood glucose meter and insulin pens using GSM and Bluetooth wireless technology. Such factors are anticipated to boost the diabetic injection pens market during the forecast period.
Research objectives:-
– To study and analyze the global Diabetic Injection Pens consumption (value & volume) by key regions/countries, product type and application, history data.
– To understand the structure of the Diabetic Injection Pens market by identifying its various sub-segments.
– Focuses on the key global Diabetic Injection Pens manufacturers, to define, describe and analyze the sales volume, value, market share, market competitive landscape, SWOT analysis, and development plans in the next few years.
– To analyze the Diabetic Injection Pens with respect to individual growth trends, future prospects, and their contribution to the total market.
– To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Have any query? Inquiry about report at: https://www.marketindustryreports.com/inquiry/246
Table of Contents
- INTRODUCTION
- Market Definition
- Market Classification
- Geographic Scope
- Years Considered for the Study: Historical Years – 2016 & 2017; Base Year – 2018; Forecasted Years – 2019 to 2030
- Currency Used
- RESEARCH METHODOLOGY
- Research Framework
- Data Collection Technique
- Data Sources
- Market Estimation Methodology
- Data Validation and Triangulation
- ABSTRACT OF THE STUDY
- MARKET DYNAMICS ASSESMENT
- Overview
- Drivers
- Barriers/Challenges
- Opportunities
- UNIQUE SELLING PROPOSITIONS (USPs)
- Technological Advancements
- Epidemiological Assessment
- GLOBAL DIABETIC INJECTION PENS MARKET – ANALYSIS & FORECAST, BY USAGE
- Reusable Pens
- Disposable Pens
- GLOBAL DIABETIC INJECTION PENS MARKET – ANALYSIS & FORECAST, BY PRODUCT TYPE
- Insulin Pens
- Pen Needles
- GLOBAL DIABETIC INJECTION PENS MARKET – ANALYSIS & FORECAST, BY DISTRUBUTION CHANNEL
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- GLOBAL DIABETIC INJECTION PENS – ANALYSIS & FORECAST, BY REGION
- North America Diabetic Injection Pens Market
- Europe Diabetic Injection Pens Market
- Asia Pacific Diabetic Injection Pens Market
- Rest of the World (ROW) Diabetic Injection Pens Market
- COMPETETIVE LANDSCAPE
- Market Positioning of Key Players (2018)
- Key Strategies Assessment
- New Usage Launches
- Merger & Acquisitions
- Agreements, Collaborations, & Partnerships
- Expansions
- Other Strategies
- COMPANY PROFILES (Business Overview, Usages Offered, Financial Performance*, Recent Developments)
- Novo Nordisk A/S
- AstraZeneca
- Eli Lilly and Company
- BD
- Sanofi
- Owen Mumford Ltd.
- Shanghai Benemae Pharmaceutical Corporation
- Jiangsu Delfu medical device Co.,Ltd
- F. Hoffmann-La Roche Ltd
- Biocon *Financial details might not be captured in case of privately-held companies or for companies that do not report this information in public domain
Buy Exclusive Report @ https://www.marketindustryreports.com/checkout/246
In the end, Diabetic Injection Pens industry report specifics the major regions, market scenarios with the product price, volume, supply, revenue, production, and market growth rate, demand, forecast and so on. This report also presents SWOT analysis, investment feasibility analysis, and investment return analysis.
About Market Industry Reports-
Market Industry Reports is a global leader in market measurement & advisory services, Market Industry Reports is at the forefront of innovation to address the worldwide industry trends and opportunities. We identified the caliber of market dynamics & hence we excel in the areas of innovation and optimization, integrity, curiosity, customer and brand experience, and strategic business intelligence through our research.
We continue to pioneer state-of-the-art approach in research & analysis that makes complex world simpler to stay ahead of the curve. By nurturing the perception of genius and optimized market intelligence we bring proficient contingency to our clients in the evolving world of technologies, megatrends and industry convergence. We empower and inspire Vanguards to fuel and shape their business to build and grow world-class consumer products.
Contact Us-
Email: sales@marketindustryreports.com
Phone: + 91 8956767535
Website: https://www.marketindustryreports.com
